| 000 | 01283 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511130739.0 | ||
| 264 | 0 | _c19790226 | |
| 008 | 197902s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00607443 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, J R | |
| 245 | 0 | 0 |
_aIntramuscular or intravenous glucagon for sulphonylurea hypoglycaemia? _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cNov 1978 |
||
| 300 |
_a125-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChlorpropamide _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhenformin _xadverse effects |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSherratt, H S | |
| 700 | 1 | _aDavies, D M | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 14 _gno. 2 _gp. 125-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00607443 _zAvailable from publisher's website |
| 999 |
_c385574 _d385574 |
||